Cerus Corp
CERS Real Time Price USDRecent trades of CERS by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CERS's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$40,000 Apr 16, 2025 Issue: Budget/Appropriations Defense
-
$40,000 Jan 20, 2025 Issue: Budget/Appropriations Defense
-
$40,000 Oct 21, 2024 Issue: Defense Budget/Appropriations
-
$40,000 Jul 21, 2024 Issue: Defense Budget/Appropriations
-
$40,000 Apr 22, 2024 Issue: Defense Budget/Appropriations
-
$40,000 Jan 21, 2024 Issue: Health Issues Defense Budget/Appropriations
-
$40,000 Oct 20, 2023 Issue: Health Issues Defense Budget/Appropriations
-
$40,000 Jul 20, 2023 Issue: Health Issues Defense Budget/Appropriations
-
$40,000 Jan 20, 2023 Issue: Defense Government Issues Health Issues Budget/Appropriations
-
$40,000 Oct 20, 2022 Issue: Government Issues Health Issues Budget/Appropriations
-
$40,000 Jul 20, 2022 Issue: Health Issues Budget/Appropriations
-
$40,000 Apr 17, 2022 Issue: Health Issues Budget/Appropriations
-
$40,000 Jan 20, 2022 Issue: None
-
$40,000 Oct 20, 2021 Issue: None
-
$40,000 Jul 20, 2021 Issue: None
-
$40,000 Apr 20, 2021 Issue: None
-
$30,000 Jan 21, 2021 Issue: None
-
$30,000 Oct 20, 2020 Issue: None
-
$30,000 Jul 20, 2020 Issue: None
-
$30,000 Apr 20, 2020 Issue: None
-
$30,000 Jan 21, 2020 Issue: None
-
$30,000 Oct 21, 2019 Issue: Health Issues Budget/Appropriations
-
$30,000 Jul 22, 2019 Issue: Budget/Appropriations
-
$30,000 Apr 22, 2019 Issue: Defense Budget/Appropriations
-
$20,000 Jan 22, 2019 Issue: Budget/Appropriations Defense Health Issues
-
$20,000 Oct 22, 2018 Issue: Government Issues Defense Health Issues Budget/Appropriations
-
$20,000 Jul 20, 2018 Issue: Defense Budget/Appropriations
-
$20,000 Jul 19, 2018 Issue: Health Issues
-
$20,000 Apr 20, 2018 Issue: Budget/Appropriations Defense
-
$20,000 Jan 22, 2018 Issue: Defense Health Issues Budget/Appropriations
-
$20,000 Oct 20, 2017 Issue: Defense Health Issues Budget/Appropriations Government Issues
-
$20,000 Jul 24, 2017 Issue: Budget/Appropriations Defense Health Issues
-
$20,000 Apr 20, 2017 Issue: Budget/Appropriations Defense
-
$20,000 Jan 23, 2017 Issue: Budget/Appropriations Government Issues
-
$20,000 Oct 19, 2016 Issue: Budget/Appropriations Government Issues
-
$20,000 Jul 19, 2016 Issue: Government Issues Budget/Appropriations
-
$20,000 Apr 19, 2016 Issue: Budget/Appropriations Government Issues
-
$20,000 Jan 20, 2016 Issue: Budget/Appropriations Government Issues
-
$20,000 Oct 20, 2015 Issue: Budget/Appropriations
-
$20,000 Jul 20, 2015 Issue: Budget/Appropriations
-
$20,000 Apr 17, 2015 Issue: Budget/Appropriations
-
$20,000 Jan 20, 2015 Issue: Health Issues Budget/Appropriations
-
$20,000 Oct 20, 2014 Issue: Health Issues Budget/Appropriations
-
$20,000 Jul 18, 2014 Issue: Budget/Appropriations
-
$20,000 Apr 18, 2014 Issue: Budget/Appropriations
-
$20,000 Jan 21, 2014 Issue: Budget/Appropriations
-
$20,000 Oct 21, 2013 Issue: Budget/Appropriations
-
$20,000 Jul 19, 2013 Issue: Budget/Appropriations
-
$20,000 Apr 22, 2013 Issue: Government Issues Budget/Appropriations
-
$20,000 Jan 18, 2013 Issue: Budget/Appropriations Government Issues
-
$20,000 Oct 19, 2012 Issue: Government Issues Budget/Appropriations
-
$20,000 Jul 19, 2012 Issue: Budget/Appropriations Government Issues
-
$20,000 Apr 20, 2012 Issue: Government Issues
-
$20,000 Jan 13, 2012 Issue: Defense Budget/Appropriations
-
$20,000 Oct 20, 2011 Issue: Government Issues Defense Budget/Appropriations
-
$20,000 Jul 20, 2011 Issue: Defense Budget/Appropriations Government Issues
-
$20,000 Apr 20, 2011 Issue: Defense Budget/Appropriations Government Issues
-
$20,000 Jan 20, 2011 Issue: Budget/Appropriations Defense
-
$20,000 Oct 19, 2010 Issue: Defense Budget/Appropriations
-
$20,000 Jul 20, 2010 Issue: Defense Budget/Appropriations
-
$20,000 Apr 19, 2010 Issue: Defense Budget/Appropriations
-
$20,000 Jan 19, 2010 Issue: Defense Budget/Appropriations
-
$20,000 Oct 16, 2009 Issue: Defense Budget/Appropriations
-
$20,000 Jul 15, 2009 Issue: Budget/Appropriations Defense
-
$20,000 Apr 17, 2009 Issue: Defense Budget/Appropriations
-
$20,000 Jan 16, 2009 Issue: Budget/Appropriations Defense
-
$20,000 Oct 20, 2008 Issue: Budget/Appropriations Defense
-
$20,000 Jul 09, 2008 Issue: Budget/Appropriations Defense
-
$20,000 Apr 21, 2008 Issue: Budget/Appropriations Defense
-
$60,000 Feb 11, 2008 Issue: Budget/Appropriations Defense
-
$60,000 Aug 08, 2007 Issue: Defense Budget/Appropriations
-
$60,000 Feb 07, 2007 Issue: Budget/Appropriations Defense
-
$60,000 Aug 23, 2006 Issue: Defense Budget/Appropriations
-
$60,000 Feb 28, 2006 Issue: Budget/Appropriations
-
$40,000 Aug 22, 2005 Issue: Defense Budget/Appropriations
-
$40,000 Mar 02, 2005 Issue: Defense Budget/Appropriations
-
$20,000 Aug 23, 2004 Issue: Budget/Appropriations Defense
-
$20,000 Mar 15, 2004 Issue: Budget/Appropriations Defense
-
$40,000 Aug 14, 2003 Issue: Budget/Appropriations Defense
Estimated quarterly lobbying spending
CERS Revenue by Segment or Geography
New patents grants
-
Patent Title: Systems and methods for treating biological fluids Feb. 04, 2025
-
Patent Title: Illuminator device Sep. 17, 2024
-
Patent Title: Kits and methods for preparing pathogen-inactivated platelet compositions Aug. 20, 2024
-
Patent Title: Illuminator device Jul. 16, 2024
-
Patent Title: Biological fluid treatment systems Jun. 18, 2024
-
Patent Title: System and methods for implementing a biological fluid treatment device Jan. 30, 2024
-
Patent Title: Systems and methods for treating biological fluids Jan. 17, 2023
-
Patent Title: Kits and methods for preparing pathogen-inactivated platelet compositions Feb. 01, 2022
-
Patent Title: Cryoprecipitate compositions and methods of preparation thereof Aug. 24, 2021
-
Patent Title: Methods for preparing platelet products Nov. 24, 2020
-
Patent Title: Plasma compositions and methods of use thereof Oct. 13, 2020
-
Patent Title: Compositions and methods for improved car-t cell therapies Jun. 23, 2020
-
Patent Title: Pathogen-inactivated red blood cell compositions Jul. 23, 2019
-
Patent Title: Pathogen-inactivated red blood cell compositions Jul. 25, 2017
-
Patent Title: Adsorbing pathogen-inactivating compounds with porous particles immobilized in a matrix Feb. 16, 2016
-
Patent Title: Quenching methods for red blood cell pathogen inactivation Dec. 02, 2014
-
Patent Title: Quenching methods for red blood cell inactivation process Feb. 02, 2010
Federal grants, loans, and purchases
- $14,925 2025-05-07 00:00:00 Agency: Department of Health and Human Services
- $28,925 2025-04-01 00:00:00 Agency: Department of Health and Human Services
- $32,121,523 2024-09-20 00:00:00 Agency: Department of Health and Human Services
- $32,121,523 2024-09-20 00:00:00 Agency: Department of Health and Human Services
- $119,950 2022-01-11 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $56,650 2021-09-10 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $71,360 2021-08-27 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $62,080 2021-08-03 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $59,000 2021-07-26 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
Estimated quarterly amount awarded from public contracts
Recent insights relating to CERS
Recent picks made for CERS stock on CNBC
ETFs with the largest estimated holdings in CERS
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $CERS stock a Buy, Sell, or Hold?
- What is the price target for $CERS stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $CERS stock?
- Who owns the most shares of $CERS stock?
- What funds own $CERS stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CERS Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.